Su idioma
Su idioma
Fucithalmic®

Look again at how you treat bacterial conjunctivitis or blepharitis.

Safety Information

Fucithalmic is well tolerated with mild and transient adverse events. Based on clinical studies, it is considered to have a more favourable adverse effect profile than chloramphenicol and norfloxacin.1,2-4,5
Special warnings and precautions for use:

Contraindications:

Hypersensitivity to fusidic acid, sodium fusidate, or any of the excipients.

Adverse events:

Application site reactions, including pain, itching and irritation/discomfort inside or outside the eyes were most frequently reported undesirable effects during treatment occurring in 8.5% of the patients based on pooled data from clinical studies and spontaneous reports. The next common undesirable effect was blurred vision in 1.2% of the patients. Post-marketing reports have shown angio-oedema in a few patients.

Drug interactions:

None known.

Effects on ability to drive and use machines:

Fucithalmic drops do not have an effect on the ability to drive and use machines, or said effect is negligible. The patients should be aware that Fucithalmic may cause transient blurring of vision following application of the drops.

Pregnancy and lactation:

Can be administered during pregnancy if considered necessary and can be used during breastfeeding.

REFERENCES:

  1. Global Market Research conducted on bacterial conjunctivitis in 5 countries in 278 patients (Concordia Rx - Fucithalmic® . Bacterial Conjunctivitis: Patient Market Research - Data on File. June 2018)
  2. Wall AR et al. J Clin Res 1998;1:316–25.
  3. Carr WD. J Clin Res 1998;1:403–11.
  4. Dirdal M. Acta Ophthalmol (Copenh) 1987;65:129–33.
  5. Hvidberg J. Acta Ophthalmologica 1987;65:43–7.